New York State Psychiatric Institute: Substance-Related Disorders trials

The registry lists 23 Substance-Related Disorders studies with New York State Psychiatric Institute as lead sponsor. 2 are open to participants now and 9 have results posted.

Phase 1 3Phase 2 8Phase 3 2Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brief Intervention Addressing Stigma Among Parents of Children With Mental Health ProblemsNot yet recruitingNCT07594730Not applicable
• Mindfulness-Based Substance Use Prevention (MINDS-UP)Not yet recruitingNCT06593470Not applicable
• Leveraging Social Networks to Increase COVID-19 Testing UptakeCompletedNCT04873401Not applicableResults posted
• Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)CompletedNCT03369249Not applicableResults posted
• Web-based Addiction Treatment: Cultural Adaptation With American IndiansCompletedNCT03363256Not applicableResults posted
• Pharmacogenetics of Naltrexone for Stimulant AbuseCompletedNCT03226223Phase 2Results posted
• Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use DisorderCompletedNCT03169816Phase 2/3Results posted
• Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3CompletedNCT03048552Not applicableResults posted
• Training Clinicians in Motivational InterviewingCompletedNCT01065480Not applicableResults posted
• Combined Treatment for Alcohol-Dependent Individuals With PTSDCompletedNCT00262223Phase 2Results posted
• Prescription Opioid Effects in Abusers Versus Non-AbusersCompletedNCT00158184Phase 2Results posted
• Cognitive Functioning in Opioid Use DisorderTerminatedNCT05001789Not applicable
• Anti-suicidal Effects of Buprenorphine in Opioid Use DisorderWithdrawnNCT04234516Phase 4
• Effects of Cannabis on Prescription Drug Abuse Liability and AnalgesiaCompletedNCT03679949Phase 1
• Medication-Assisted Treatment for Youth With Substance Use DisordersCompletedNCT02593474Phase 1
• Cognitive Skills Training for Homeless YouthCompletedNCT01815398Not applicable
• HIV/STI Prevention for Adolescents With Substance Use Disorders in TreatmentCompletedNCT01383837Phase 1/2
• Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use DisordersCompletedNCT01104805Not applicable
• Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareCompletedNCT00471042
• Women's Treatment for Trauma and Substance Use Disorders - 1CompletedNCT00078156Phase 3
• Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
• A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
• New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2